173 related articles for article (PubMed ID: 16973621)
21. NEK5 interacts with topoisomerase IIβ and is involved in the DNA damage response induced by etoposide.
Melo-Hanchuk TD; Slepicka PF; Pelegrini AL; Menck CFM; Kobarg J
J Cell Biochem; 2019 Oct; 120(10):16853-16866. PubMed ID: 31090963
[TBL] [Abstract][Full Text] [Related]
22. Effect of the anti-neoplastic drug doxorubicin on XPD-mutated DNA repair-deficient human cells.
Saffi J; Agnoletto MH; Guecheva TN; Batista LF; Carvalho H; Henriques JA; Stary A; Menck CF; Sarasin A
DNA Repair (Amst); 2010 Jan; 9(1):40-7. PubMed ID: 19926538
[TBL] [Abstract][Full Text] [Related]
23. Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide.
Sunter NJ; Cowell IG; Willmore E; Watters GP; Austin CA
J Nucleic Acids; 2010 Aug; 2010():. PubMed ID: 20847952
[TBL] [Abstract][Full Text] [Related]
24. SCF
Shu J; Cui D; Ma Y; Xiong X; Sun Y; Zhao Y
Oncogenesis; 2020 Feb; 9(2):8. PubMed ID: 32015321
[TBL] [Abstract][Full Text] [Related]
25. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
[TBL] [Abstract][Full Text] [Related]
26. The retinoblastoma tumor suppressor protein is required for efficient processing and repair of trapped topoisomerase II-DNA-cleavable complexes.
Xiao H; Goodrich DW
Oncogene; 2005 Dec; 24(55):8105-13. PubMed ID: 16091739
[TBL] [Abstract][Full Text] [Related]
27. The Role of DNA Topoisomerase Binding Protein 1 (TopBP1) in Genome Stability in
Parra-Nunez P; Cooper C; Sanchez-Moran E
Plants (Basel); 2021 Nov; 10(12):. PubMed ID: 34961037
[TBL] [Abstract][Full Text] [Related]
28. Role of DNA topoisomerase IIbeta in neurite outgrowth.
Nur-E-Kamal A; Meiners S; Ahmed I; Azarova A; Lin CP; Lyu YL; Liu LF
Brain Res; 2007 Jun; 1154():50-60. PubMed ID: 17493591
[TBL] [Abstract][Full Text] [Related]
29. The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II.
Auzanneau C; Montaudon D; Jacquet R; Puyo S; Pouységu L; Deffieux D; Elkaoukabi-Chaibi A; De Giorgi F; Ichas F; Quideau S; Pourquier P
Mol Pharmacol; 2012 Jul; 82(1):134-41. PubMed ID: 22528119
[TBL] [Abstract][Full Text] [Related]
30. Alternative RNA Processing of Topoisomerase IIα in Etoposide-Resistant Human Leukemia K562 Cells: Intron Retention Results in a Novel C-Terminal Truncated 90-kDa Isoform.
Kanagasabai R; Serdar L; Karmahapatra S; Kientz CA; Ellis J; Ritke MK; Elton TS; Yalowich JC
J Pharmacol Exp Ther; 2017 Jan; 360(1):152-163. PubMed ID: 27974648
[TBL] [Abstract][Full Text] [Related]
31. The efficacy of topoisomerase II-targeted anticancer agents reflects the persistence of drug-induced cleavage complexes in cells.
Bandele OJ; Osheroff N
Biochemistry; 2008 Nov; 47(45):11900-8. PubMed ID: 18922022
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of repair of 5'-topoisomerase II-DNA adducts by mammalian tyrosyl-DNA phosphodiesterase 2.
Schellenberg MJ; Appel CD; Adhikari S; Robertson PD; Ramsden DA; Williams RS
Nat Struct Mol Biol; 2012 Dec; 19(12):1363-71. PubMed ID: 23104055
[TBL] [Abstract][Full Text] [Related]
33. Replicative helicases can translocate through abasic site-induced covalent topoisomerase IV-DNA complexes.
Shea ME; Hiasa H
Nucleic Acids Res; 2001 Feb; 29(3):614-21. PubMed ID: 11160881
[TBL] [Abstract][Full Text] [Related]
34. PP2A-B56ϵ complex is involved in dephosphorylation of γ-H2AX in the repair process of CPT-induced DNA double-strand breaks.
Li X; Nan A; Xiao Y; Chen Y; Lai Y
Toxicology; 2015 May; 331():57-65. PubMed ID: 25772433
[TBL] [Abstract][Full Text] [Related]
35. Various inhibitors of DNA topoisomerases diminish repair-specific DNA incision in UV-irradiated human fibroblasts.
Thielmann HW; Popanda O; Gersbach H; Gilberg F
Carcinogenesis; 1993 Nov; 14(11):2341-51. PubMed ID: 8242865
[TBL] [Abstract][Full Text] [Related]
36. Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage.
Adachi N; Suzuki H; Iiizumi S; Koyama H
J Biol Chem; 2003 Sep; 278(38):35897-902. PubMed ID: 12842886
[TBL] [Abstract][Full Text] [Related]
37. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
[TBL] [Abstract][Full Text] [Related]
38. Monoubiquitinated γ-H2AX: Abundant product and specific biomarker for non-apoptotic DNA double-strand breaks.
Luczak MW; Zhitkovich A
Toxicol Appl Pharmacol; 2018 Sep; 355():238-246. PubMed ID: 30006243
[TBL] [Abstract][Full Text] [Related]
39. Cell cycle activation in postmitotic neurons is essential for DNA repair.
Schwartz EI; Smilenov LB; Price MA; Osredkar T; Baker RA; Ghosh S; Shi FD; Vollmer TL; Lencinas A; Stearns DM; Gorospe M; Kruman II
Cell Cycle; 2007 Feb; 6(3):318-29. PubMed ID: 17297309
[TBL] [Abstract][Full Text] [Related]
40. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
